524 results about "Dithiothreitol" patented technology

The invention relates to a pathological examination, in particular to a liquid-based cell preservation solution used in cytopathological examination of human cervical mucus, sputum, urine, pleural fluid, tracheal mucus and the like. It is characterized in that it is prepared from alcohols, sodium phosphate buffer, edetate disodium, sodium chloride 0.08%-0.12%, potassium chloride, formaldehyde, dithiothreitol, calcium acetate, magnesium acetate, etc. As a result, it can not only maintain the stability of the cell structure. It can reduce the agglomeration and precipitation of cell mucus and the loss of cell rupture, and can also make cells easy to stain, improve the clarity of cell preparation, facilitate the smooth progress of pathological examination, and the cost is low, which is conducive to popularization and use.

The invention provides nanoparticle-bioconjugate probes that are useful for detecting target analytes such as nucleic acids. The probes of the invention are stable towards heat and resistant to displacement by thiol containing compounds such as DTT (dithiothreitol).

A method the direct analysis of an analyte in keratinized structures, e.g., hair and fingernails, which comprises preparing a mixture containing a low redox potential activator compound such as dithiothreitol or dithioerythritol, an enzyme suitable for the digestion of the keratin structure, a sample of the keratin structure and a biological detergent that aids the digestion of the keratinized structure at a relatively low pH, e.g., between about 6.2 and 8; permitting the enzyme to at least substantially digest the sample of keratin structure, and subjecting the digest solution to analysis, preferably by radioimmunoassay, to determine the identity and amount of analyte in the keratin structure sample. To accelerate the method, cupric sulfate may be added to the mixture after degradation of the keratin sample. The enzyme may be a peptidase, endopeptidase or proteinase, with papain, chymopapain, and proteinase K being preferred for use in the invention. The preferred biological detergents include betaine, sulfo-betaine, alkylglucosides and bile acids.

The invention relates to a quantitative detection method for thermal-denaturation and non-denaturation bovine alpha-lactalbumin in milk and milk products by applying an enzymolysis-liquid chromatography and mass spectrometry combination technology. The quantitative detection method comprises the steps as follows: taking a certain amount of milk or milk samples, dissolving and diluting the milk or milk samples in water to obtain solution with total protein content being about 1mg / mL; after volume metering, correctly sucking 500 mu L, adding an internal standard substance, reacting disulfide bond with dithiothreitol (DTT), alkylating to protect sulfydryl produced in reaction by iodoacetamide (IAA), and then conducting constant-temperature and constant-time enzymolysis with trypsin; and separating enzymolysis products by reversed phase liquid chromatography, conducting detection with a mass spectrum multiple reaction monitoring (MRM) manner, and calculating the result by an internal standard method. The quantitation limit of the method is 0.001g / 100g; when adding amount is 0.2, 1.7 and 5.0g / 100g, the recovery rate is 98.9-110.8% (n is equal to 6) and repeatability: RSD (Relative Standard Deviation) is smaller than 7.6%; and the quantitative detection method can be applicable to the quantitative detection of samples with different contents of bovine alpha-lactalbumin.

The present invention relates to a method for isolating and culturing adult stem cells derived from human amniotic membrane in high yield, and more particularly to a method for obtaining a large amount of adult stem cells, the method comprising obtaining amniotic epithelial cells from human amniotic tissue in high yield by treatment with dithiothreitol (DTT) and a low concentration of trypsin and culturing the amniotic epithelial cells in a medium containing a Rho-associated kinase inhibitor. The human amniotic epithelial cell-derived stem cells are easily extracted compared to existing therapeutic stem cells such as umbilical cord blood stem cells and bone marrow stem cells, the yield and proliferation thereof are significantly increased by DTT treatment, the addition of the ROCK inhibitor or the replacement of medium. Thus, the method can be used to efficiently prepare adult stem cells.

The present invention relates to a natural deodorant system and a natural system for topical and systemic delivery of active ingredients, both systems being primarily free of, preferably substantially free of, more preferably essentially free of, and most preferably completely free of ethoxylates or other petrochemical derivatives, and comprising: (a) at least one of (1) glycerine (preferably of plant origin), (2) a polyol selected from the group consisting of galactitol, erythritol, inositol, ribitol, dithioerythritol, dithiothreitol, (3) a sugar alcohol, selected from the group consisting of mannitol, sorbitol, xylitol and maltitol, (4) a hydrogenated starch hydrosylates of at least one of berries, apples or plums, and (5) mixtures thereof; (b) water or a lower monohydric alcohol, selected from the group of methanol, ethanol, propanol and isoproponal, or mixtures thereof, present at a combined concentration of at least 20%; (c) one or more carrageenans (preferably of plant origin) or alginates, or mixtures thereof, present in combined concentrations of less than about 2%; and (d) optionally, one or more thickeners or gums selected from the group consisting of tara, guar, xanthan, Arabic, tragacanth, agar, locust bean gum, ghatti and microcrystalline celluloses.

The invention provides a method and a PCR (polymerase chain reaction) reagent kit for identifying DNA (deoxyribonucleic acid) barcodes of animal medicinal materials. The PCR reagent kit comprises PCR enhancers. The PCR enhancers comprise bovine serum albumin, dithiothreitol, betaine and nonidet p40. The method and the PCR reagent kit for identifying the DNA barcodes of the animal medicinal materials have the advantages that low-abundance traditional Chinese medicine samples with difficulty in amplification, particularly, samples with difficulty in identifying DNA barcodes, such as samples of buffalo horns, antelope horns, tortoise shells, carapax trionycis, pangolins and snake slough, can be effectively amplified, accordingly, the amplification success rate which is close to 100%, of DNA barcode identification techniques can be guaranteed, and DNA barcode techniques can be widely applied.

The invention relates to the technical field of detection of ischemia modified albumin content, and in particular to a detection kit for ischemia modified albumin. The kit includes a reagent 1 and a reagent 2. The reagent 1 contains a buffer, cobalt chloride, a stabilizer and a preservative; and the reagent 2 contains a buffer, dithiothreitol, a stabilizer, a reducing protective agent and a preservative. The kit can accelerate the binding efficiency of cobalt ions with normal albumin, and the cobalt ions fully integrate with normal albumin in a certain period of time, so as to ensure the accuracy of the detection result on a sample by the reagent; the kit protects the stability of dithiothreitol in the solution, and does not affect the binding of dithiothreitol with cobalt ions, so as to ensure that an open reagent bottle can be stably kept in a dark place for 30 days at room temperature and a closed reagent bottle can be stably kept at 2-8 DEG C for 12 months, and fully meet the needs of clinical laboratory; and the kit accelerates the combination of dithiothreitol with cobalt ions, so that the reagents reach reaction endpoints as soon as possible, thereby ensuring the efficient detection effect of reagents and significantly improving the accuracy of reagent detection.

The invention discloses a method for re-crystallizing, refining and purifying sugammadex sodium. The method comprises the following steps: adding a protective agent to crude sugammadex sodium, and performing re-crystallizing under the protection of an inert gas to obtain pure sugammadex sodium, wherein the protective agent is selected from one or a mixture of two or more of mercaptoethanol, mercaptoacetate, mercaptoacetate ester, mercaptopropionate, mercaptopropionate ester, glutathione, cysteine, cystamine, dithioerythritol, dithiothreitol, trisubstituted organophosphorus compounds and trisubstituted organophosphorus compound salts. The method has the advantages of simplicity in operation, high product purity, good economy, and suitableness for industrial production.

The invention discloses an isothermal nucleic acid amplification reaction reagent which comprises Tris buffer solutions, potassium acetate, magnesium acetate, dithiothreitol, polyethylene glycol, adenosine triphosphate (ATP), deoxy-ribonucleoside triphosphate (dNTPs), phosphocreatine, creatine kinase, a primer group, single-strand binding (SSD) protein, colon bacillus helicase RecQ protein, UvsY protein and DNA polymerase. The invention further discloses an isothermal nucleic acid amplification method which includes steps of extracting DNA or performing inverse transcription after DNA extracting, and adding the isothermal nucleic acid amplification reaction reagent and reacting the mixture at a temperature in a range between 25 DEG C and 45 DEG C for 10 minutes to 60 minutes to complete the nucleic acid amplification. Compared with traditional polymerase chain reaction (PCR) technologies and according to the technology, nearly no professional instrument is needed, the operation is simple, technical requirements for operators are low, and the reaction time only needs about half an hour.

The invention discloses a swab eluting solution with sample preservation and inactivation functions. The swab eluting solution is prepared from guanidinium isothiocyanate, ethylenediamine tetraacetic acid, a buffering solution, dithiothreitol, a surfactant, glass beads or polypropylene plastic beads and de-ionized water, wherein the contents of the components in the eluting solution are as follows: 20 weight / volume percent to 55 weight / volume percent of the guanidinium isothiocyanate, 1mM to 25mM of the ethylenediamine tetraacetic acid, 20mM to 100mM of the buffering solution, 1 weight / volume percent to 5 weight / volume percent of the dithiothreitol, 1 percent to 5 percent of the surfactant and 3 to 10 glass beads or polypropylene plastic beads. The prepared eluting solution is low-cost and stable in performance; the prepared eluting solution can be used for preserving DNA / RNA (Deoxyribonucleic Acid / Ribonucleic Acid), and elution and normal-temperature preservation and transportation of a swab sample are realized; pathogens can be inactivated, so that the swab eluting solution has a sample inactivation effect, and risks of exposed infection in a laboratory can be greatly reduced; the guanidinium isothiocyanate which is used in the eluting solution is a common chemical component for extracting nucleic acid, so that the subsequent extraction of the nucleic acid is not influenced.

The invention relates to a method for inhibiting degradation of a decarburization amine absorbent. Specifically, certain amount of antioxidant is added into the amine absorbent to inhibit degradation of the amine absorbent. The used antioxidant can be xylitol, threitol, dithiothreitol, erythritol, ethylene glycol, butanediol and other structurally similar alcohol compounds. By means of the principles of interrupting an oxidation reaction chain and decomposing an oxidative degradation product, the antioxidant can achieve significant antioxidant effects, and can be used under the circumstances of small adding amount, high temperature and wide oxygen content, thus greatly inhibiting degradation of amine water solution. Stability of a recovery solvent and continuous operation of separation equipment are ensured, the degree of corrosion caused by an absorption solvent on equipment can be reduced, and meanwhile the absorbent loss is also reduced. The method can be used for antioxidation of amine absorption solvents applied in capture and separation of carbon dioxide (CO2) from natural gas, shift gas, synthetic gas, flue gas and other industrial feed gas.

The invention discloses a method for extracting RNA from gymnosperm tissues. The method includes the following steps: 1) extracting buffer solution by RNA to treat plant materials; 2) protein removal: extracting by equal-volume chloroform / isoamylol for twice; 3) using LiCl to deposit RNA and SSTE to dissolve back RNA; 4) glycan removal: adding absolute ethyl alcohol and potassium acetate to the dissolved solution acquired in step 3) and depositing glycan in ice bath; 5) extracting chloroform / isoamylol again; 6) depositing RNA and DEPC H2O again to dissolve back RNA. In order to remove DNA, the following steps can be also conducted: a) using DNase without RNase pollution to remove DNA; b) using chloroform / isoamylol to extract and remove DNase; (c) repeating step 6). Wherein, RNA extract and buffer solution contains 100mmol / L Tris HCl(pH 8.0), 2g / 100mlCTAB, 2g / 100mlPVP, 2mol / LNaCl and 25mmol / L EDTA and is added with dithiothreitol with final concentration of 10mmol / L and 2 percent (volume percentage) of beta-mercaptoethanol. Therefore, the invention solves the interference of glycan and polyphenol and the like and acquires high-purity RNA.

The invention provides a preservative composition of blood DNA. The preservative composition of blood DNA comprises, by weight, 20 to 50 parts of a preservative, 5 to 15 parts of an anticoagulant, 0.5 to 5 parts of a nuclease inhibitor, 1 to 5 parts of a metabolic inhibitor and 40 to 70 parts of water, wherein the nuclease inhibitor comprises one or more of diatomite, bentonite, ethyl alcohol, formamide, vanadyl-ribonucleoside complex, dithioerythritol, diethyl pyrocarbonate, proteinase-K, heparin, beta-mercaptoethanol, hydroxylamine-O-copper ions, ammonium sulfate, dithiothreitol, cysteine, and 4-formylbenzoic acid and oxovanadium Schiff base complex.

The invention discloses a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay kit and a detection method for grass carp reoviruses (GCRV), and belongs to the technical field of the detection of fish viruses. The RT-LAMP assay kit for the grass carp reoviruses comprises the following ingredients: 1*ThermoPol Reaction Buffer, Bacillus stearothermophilus deoxyribonucleic acid (BstDNA) polymerase, deoxyribonucleotide triphosphate (dNTPs), AMV reverse transcriptase, outer primers (F3 and B3), inner primers (FIP and BIP), Betaine, MgCl2, dithiothreitol (DTT) and 1,000*SYBR Green I. The assay kit has the characteristics of simpleness, convenience, quickness and high specificity and sensitivity; GCRV-104 in a sample can be accurately detected within 2 hours only by using a water bath kettle or metal bath; and the assay kit can detect grass carp tissues infected by the GCRV-104 and cells (such as cytokine-induced killer (CIK) cells) infected by the GCRV-104, and is applicable to the on-site rapid detection of the GCRV-104.

The invention relates to a neuron-specific enolase stabilizer. The stabilizer is prepared from a Tris.HCl buffer solution, NaCl, sucrose, trehalose, casein, bovine serum albumin, PEG6000, lysine, disodium ethylene diamine tetraacetate, dithiothreitol, glycerin, Tween-20, Triton X-100, aprotinin with the final concentration of 100-300 KIU / mL, and Proclin 300, and above substances are uniformly mixed in Millipore ultrapure water used as a solvent, is filtered by a 0.22 [mu]m filter membrane, and finally is preserved at 0-10 DEG C. The stabilizer greatly improves the preservation stability of neuron-specific enolase, prolongs the shelf life of a kit, simplification of the production technology and the doctor's detection operation process of a neuron-specific enolase detection kit, improvement of the metamorphism resistance in the preparation, transportation and storage process of the neuron-specific enolase, and reduction of inter-assay variation caused by a freeze-drying technology.

The invention relates to a method of promoting keratin dissolution and enhancing strength of a keratin material. The keratin relates to water-insoluble keratin or keratin the solubility of which in water is low, and is characterized in that the disulfide bond content of the keratin is high. The method of promoting dissolution of the water-insoluble keratin includes adding the keratin into an aqueous solution, and adding a certain amount of a reductant at the same time to break disulfide bonds to form free mercapto groups, thus promoting keratin dissolution. The reductant includes cysteine, dithiothreitol, glutathione, mercaptan and sodium pyrosulfite, or keratin or peptides with reducibility, or other compounds capable of inducing disulfide bond breakage and formation of the free mercapto groups, such as proteins or peptides with reducibility. The method is also characterized in that the dissolved keratin comprises the free mercapto groups so that the dissolved keratin can be subjected to disulfide bond crosslinking again under oxidation conditions, thus significantly improving mechanical strength of the keratin material. The keratin material can includes keratin hydrogel, film, sponge, fibers, and a plurality of other forms.

A new method of simultaneous and separate extraction of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) from a biological sample, indifferently from fresh, frozen, fixed or autoptic tissue with a weight no less than 5 mg. The main steps of the method are: 1 / sample lysis in a solution composed of a caotropic agent (urea or guanidine salt), a ionic detergent (SDS or SLS), a proteolytic enzyme (proteinase K, trypsin, chymotrypsin, pepsin or pronase), a reducing agent (β-mercaptoethanol or dithiothreitol); 2 / deproteination; 3 / precipitation of RNA from aqueous phase; 4 / precipitation of DNA from organic phase. The invention includes an extraction kit for nucleic acids, also of viral origin.

The present invention relates to pathological examination, especially to a liquid-based cell preservation solution used in pathologically examining cells such as human cervical mucus, sputum, urine, thoracic liquid, and tracheal mucus. The liquid-based cell preservation solution is characterized by being prepared from alcohols, a sodium phosphate buffer solution, disodium ethylenediamine tetraacetate, 0.08-0.12% sodium chloride, potassium chloride, formaldehyde, dithiothreitol, calcium acetate, magnesium acetate and the like. The cell preservation solution cannot only maintain the cell structure stability and reduce the agglomerated precipitation of the cell mucus and the cell breakage loss, but also enables the cells easily to be stained, improves the clarity of the cell sheets, and facilitates smooth performance of the examination work. Moreover, the cell preservation solution is low in cost and easy to promote and use.

The invention provides a kit and method for constructing a DNA library. The kit comprises an enzymic reagent, a buffer solution and a joint combination, wherein the enzymic reagent comprises a first enzyme mixed liquid, T4DNA ligase and a second enzyme mixed liquid, and the first enzyme mixed liquid is formed by mixing T4 Polynucleotide Kinase, T4DNA polymerase, a Klenow fragment and rTaq enzyme; the second enzyme mixed liquid is a 2X KAPA HiFi HotStart pre-mixed solution; the buffer solution comprises a first buffer solution and a second buffer solution, and the first buffer solution is formed by mixing a 10X T4DNA ligase buffer solution, dNTP mixed liquor and ATP; the second enzyme mixed liquid is formed by mixing ATP, Tris-HCL, MgCl2, PEG8000, Tween 20 and dithiothreitol; the joint combination comprises a joint sequence group and a tag sequence group. According to the kit, the library construction cost can be reduced and the amplification efficiency is improved.

The invention provides a method for preparing animal keratin base macromolecular hydrogel and an application of hydrogel serving as medicine carrier. The method comprises the steps as follows: animal keratin is dispersed in urea or a sodium hydroxide solution and then reduced by using dithiothreitol or mercaptoethanol as a reducing agent; and then N,N'-methylene bisacrylamide is used as a cross-linking agent, and polymerization of animal keratin and methacrylic acid is performed, so that the hydrogel is obtained. Experiments show that the prepared animal keratin base macromolecular hydrogel has good swelling and swelling-prevention performance as well as pH sensibility, and has a very good slow-release effect on micro-molecular model medicines, so that the hydrogel can be used as a medicine carrier and is applied to production of pharmaceutic preparations.

The invention relates to a gene diagnosis and detection core reagent transportable at normal temperature and of high sensitivity and high specificity. The reagent comprises reaction buffer, deoxyribonucleoside triphosphate (DNTP), heat resistant DNA polymerase, glycerin, bovine serum albumin (BSA), dithiothreitol (DTT) and tween-20. The reagent is characterized in that: proper amounts of polysaccharide and disaccharide are mixed into the core reagent; the reaction buffer of the reagent is composed of 5mM-50mM of Tris-HCL, 20mM-500mM of KCL, 1.0mM-5mM of MgC12 and 20mM-200mM of (NH4)2SO4; meanwhile 50uM-300uM of DNTP, 0.01U / ul-0.2U / ul of heat resistant DNA polymerase, 1mM-15mM of polysaccharide, 2M-100M of disaccharide, 3%-30% of glycerin, 10-300ug / ml of BSA, 0.5-10mM of DTT and 0.005-0.05v / v of tween-20 are mixed.

The invention discloses a liquid chromatography tandem mass spectrum method for detecting sulphur amino acids in blood plasma using a non-derivation method and belongs to the field of biochemical analysis and detection. The method comprises the steps that the blood plasma is added to an isotope internal standard solution, and a mixed solution is mixed evenly, then, dithiothreitol (DTT) is added to restore, and supernatant with the sulphur amino acids is obtained after protein precipitation treatment. A sample is pretreated by the adoption of the non-derivation method, the method is simple, the operation is easy, and the sample pretreatment procedures are greatly simplified; the interference for detection by matrix is reduced by the isotope internal standard, and the accuracy of homocysteine, cysteine and methionine detection is ensured. According to the liquid chromatography tandem mass spectrum method for detecting the sulphur amino acids in the blood plasma using the non-derivation method, an LC-MS / MS method is used for detecting the sulphur amino acids in the blood plasma, a multiple-reaction detection MRM scanning mode is adopted, cross interference between (i) d ( / i) (i) 3 ( / i) -methionine and homocysteine (136> 90 passage) exists, base lines of the cross interference are separated by elution conditions of a chromatography gradient, and the accuracy of the detection is ensured. The method is high in sensitivity, strong in specificity and accurate in result.

The invention relates to a quantum dot fluorescent probe and application thereof. The invention is characterized in that the quantum dot fluorescent probe utilizes a difunctional cross-linking agent long-chain succinimidyl-4-[N-maieimidomethyl]cyclohexane-1-carboxy-[6-amidocaproate] (SMCC) to undergo a cross-linking reaction with an amino group on the surface of an amino quantum dot; a maleimide group is produced on the surface of the quantum dot; a to-be-labeled antibody is reduced by a reducing agent dithiothreitol (DTT) so as to reduce a disulfide bond into a mercapto group; and the mercapto group and the maleimide group form a covalent bond so as to realize labeling of the quantum dot with the antibody. The quantum dot fluorescent probe is applied to (1) detection of one protein oncofetal antigen or (2) detection of a plurality of protein CEA, euron-specific enolase (NSA) and a cytokerain fragment 19CYFRA21-1, wherein the detection limit of detection (1) is 38 pg / ml, and the detection limit of detection (2) is 0.9 ng / ml.

The invention discloses a PCR amplification system and a PCR amplification method for high GC content gene, belonging to the technical field of biotechnology; the PCR amplification system comprises DNA polymerase, MgCl2, dNTP, upstream primer, downstream primer, DNA template and double distilled water; and the invention is characterized in that the PCR amplification system also comprises tri(hydroxymethyl)aminomethane hydrochloride, dithiothreitol, bovine serum albumin and additive. The PCR amplification technology in the invention can amplify target genes containing over 80% of GC, can amplify high GC content target genes with a length up to 1.5Kb and can successfully amplify template genes with different degrees of complexity and different sources such as people, animals, plants and microorganisms; in addition, the PCR amplification technology has less operating steps, short operating time, simple instruments and devices, thus being generally applicable to the scientific research and medical diagnosis.

A process for production of cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV is provided which employs a BOC-protected amine of the structure prepared by subjecting an acid of the structure to reduce amination by treating the acid with ammonium formate, nicotinamide adenine dinucleotide, dithiothreitol and partially purified phenylalanine dehydrogenase / formate dehydrogenase enzyme concentrate (PDH / FDH) and without isolating treating the resulting amine of the structure 2 with di-tert-butyl dicarbonate to form the BOC-protected amine.

The invention discloses a method of simultaneously extracting animal DNA (Deoxyribonucleic Acid) virus and RNA (Ribonucleic Acid) virus nucleic acid in blood serum and double swabs. The method comprises the following steps of: carrying out lysis on a to-be-extracted substance by using guanidinium isothiocyanate lysate; adsorbing RNA by a silica gel membrane; removing impure protein by washing liquor I; removing impurities by washing liquor II; carrying out DEPC (Diethylpyrocarbonate) water-washing to remove nucleic acid, wherein the guanidinium isothiocyanate lysate comprises 3M-7M guanidinium isothiocyanate, 0.6%-1.0% TriTon-100, 30mM-50mM Tris-Cl, 5mM-15mM DTT (DL-Dithiothreitol), 60 mu g / mL-90 mu g / mL protease K, 10mM-30mM EDTA (Ethylene Diamine Tetraacetic Acid), and PH of the guanidinium isothiocyanate lysate is 4.3-4.6; the washing liquor I comprises 5M-6M guanidine hydrochloride, 53%-59% absolute ethyl alcohol, 70-90 mu g / mL protease K, and PH of the washing liquor I is 6.4-6.6; the washing liquor II comprises 70%-80% alcohol. The method disclosed by the invention has the advantages of being simple in extracting process, short in period, low in cost, and capable of simultaneously extracting RNA virus and DNA virus nucleic acid in an animal blood serum sample and a double-swab sample.

The invention discloses a preparation method and an application of a novel quadruple-responsiveness (temperature, pH, reduction and photo-response) block polymer micelle. The preparation method of the novel quadruple-responsiveness block polymer micelle comprises the following steps: enabling an atom transfer radical polymer to react for two times so as to prepare a poly(2-nitryl benzyl methyl acrylate)-block-poly(dimethylaminoethyl methacrylate) (PNBM-SS-PDMAEMA) amphiphilic block copolymer, wherein the polymer is capable of self-assembling in water to form a nano-micelle and also capable of loading hydrophobic micromolecules (for example, nile red). The structure of the self-assembled micelle is capable of obviously changing in the presence of ultraviolet radiation, reducing agent dithiothreitol, temperature regulation and pH stimulation; and different synergetic stimulations are capable of regulating dynamic release processes of guest molecules. The polymer micelle has temperature response, pH response, reduction response and photo-response and also has a wide application prospect in the field of controlled release.

The invention discloses enzymatic catalysis crosslinking reduction-responsive hyaluronic acid microgel and a preparation method thereof. The hyaluronic acid microgel is prepared by taking sulfhydrylation hyaluronic acid as a raw material, taking horseradish peroxidase as a catalyst, taking tyramine hydrochloride as an enzymatic catalysis reaction substrate and combining the method that horseradish peroxidase is catalytically crosslinked with sulfydryl to generate a disulfide bond through an inverse emulsion method. The disulfide bond crosslinking structure in the microgel can be broken in the presence of reductive substances such as dithiothreitol, reductive glutathione hormone and L-cysteine, and then the good reduction responsiveness is given to the microgel. The hyaluronic acid microgel can achieve controlled release on the reduction responsiveness of loaded doxorubicin hydrochloride and can be applied to controlled release of tumor-targeted drugs. According to the preparation method, a crosslinking agent does not need to be additionally added into an inverse emulsion system to cure the microgel, the toxicity influence of the crosslinking agent is avoided, the biocompatibility of the microgel is guaranteed, the reaction conditions are mild, and the technological processes are simple.

The invention discloses a method for extracting total RNA (Ribonucleic Acid) from woody mangrove plants and special extracting solution thereof. The extracting solution provided in the invention comprises Tris-HCl, EDTA (Ethylene Diamine Tetraacetic Acid), NaCl, SDS (Sodium Dodecyl Sulfonate), DTT (Dithiothreitol), beta-mercaptoethanol and water, wherein the final concentration of the Tris-HCl is 75-125 mmol / L, the final concentration of the EDTA is 400-600 mmol / L, the final concentration of the NaCl is 400-600 mmol / L, the final concentration of the SDS is 1%-3% (in weight percent), the final concentration of the DTT is 3-8 mmol / L, and the final concentration of the beta-mercaptoethanol is 1%-3% (in weight percent); and the pH value is 8-9. The method provided in the invention is used for extracting the total RNA from the woody mangrove plants by using the extracting solution. The RNA extracted by the method can be directly used for synthesizing cDNA (complementary Desoxyribonucleic Acid) and carrying out molecular biology operations, such as library establishment, molecular clone and the like.